Latigo Biotherapeutics, Inc. LTGO

Set alert

12.60 USD -0.41 (-3.15%)

At closeNov 6, 2026, 5:37 PM EST

12.30 -0.30 -2.38%

After hours · Nov 6, 5:37 PM ET

12.11 Day range 15.95

12.60 52-week range 25.00

Held by insiders 4.98%

Held by institutions 80.73%

Float held by institutions 84.95%

Institutions 12

No holders on record

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Fidelity Contrafund	1.42%	940,228	14.61M	Aug 30, 2026
Fidelity Select Portfolios-Select Biotechnology Portfolio	0.72%	480,316	7.46M	Aug 30, 2026
Fidelity Select Portfolios-Select Health Care Portfolio	0.32%	212,500	3.30M	Aug 30, 2026
Fidelity Contrafund-Fidelity Contrafund K6	0.30%	199,400	3.10M	Aug 30, 2026
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund	0.29%	191,400	2.97M	Aug 30, 2026
Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund	0.16%	105,200	1.63M	Aug 30, 2026

LTGO insiders
Insider	Relation	Latest transaction	Date
5AM VENTURES VI, L.P.	Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Aug 9, 2026
FORESITE CAPITAL MANAGEMENT V, LLC.	Beneficial Owner of more than 10% of a Class of Security	Purchase	Aug 9, 2026
SANOFI SA	Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Aug 9, 2026
SEIDENBERG BETH C	Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Aug 9, 2026
TANANBAUM JAMES B	Director and Beneficial Owner of more than 10% of a Class of Security	Purchase	Aug 9, 2026
WESTLAKE BIOPARTNERS FUND I, L.P.	Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Aug 9, 2026

Held by funds